Current Understanding Of Synergistic Interplay Of Chitosan Nanoparticles And Anticancer Drugs: Merits And Challenges
Prameela Kandra, Hemalatha Padma Jyoti Kalangi
Published 2015 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Recent advances have been made in cancer chemotherapy through the development of conjugates for anticancer drugs. Many drugs have problems of poor stability, water insolubility, low selectivity, high toxicity, and side effects. Most of the chitosan nanoparticles showed to be good drug carriers because of their biocompatibility, biodegradability, and it can be readily modified. The anticancer drug with chitosan nanoparticles displays efficient anticancer effects with a decrease in the adverse effects of the original drug due to the predominant distribution into the tumor site and a gradual release of free drug from the conjugate which enhances drug solubility, stability, and efficiency. In this review, we discuss wider applications of numerous modified chitosan nanoparticles against different tumors and also focusing on the administration of anticancer drugs through various routes. We propose the interaction between nanosized drug carrier and tumor tissue to understand the synergistic interplay. Finally, we elaborate merits of drug delivery system at the tumor site, with emphasizing future challenges in cancer chemotherapy.
This paper references
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.
Daniel Torrecilla (2013)
The dawning era of polymer therapeutics
R. Duncan (2003)
Clinical relevance of MGMT in the treatment of cancer.
S. Gerson (2002)
Daten Pharm Ind
Cancer statistics, 2013
R. Siegel (2013)
A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan
H. P. Brack (1997)
Conjugate of mitomycin C with N-succinyl-chitosan: In vitro drug release properties, toxicity and antitumor activity
Y. Song (1993)
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers
C. Ashley (2011)
Immunotoxin therapy of cancer.
I. Pastan (1993)
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
D. Zaharoff (2007)
Target-Oriented Drug-Delivery Systems
V. Kumar (2002)
Pharmacokinetics and Distribution of a Biodegradable Drug-carrier
L. Grislain (1983)
Cancer statistics for african americans
C. Boring (1992)
Textbook of Medical Physiology
A. Guyton (1961)
Global requirements for medical applications of chitin and its derivatives
Mh Struszczyk (2006)
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
Handbook of hydrocolloids.
G. Phillips (2009)
Shrimp biowaste fermentation with Pediococcus acidolactici CFR2182: Optimization of fermentation conditions by response surface methodology and effect of optimized conditions on deproteination/demineralization and carotenoid recovery
N. Bhaskar (2007)
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles
J. Kattan (2004)
Bioremediation of shrimp biowaste by using natural probiotic for chitin and carotenoid production an alternative method to hazardous chemical method.
K. Prameela (2010)
Intranasal delivery to the brain
Robert I. Henkin (2011)
Quality properties of pork sausage prepared with water-soluble chitosan oligomer.
C. Jo (2001)
Impact of reporting delay and reporting error on cancer incidence rates and trends.
L. Clegg (2002)
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
Characterization of polyacryl starch microparticles as carriers for proteins and drugs.
P. Artursson (1984)
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Studium der Mizellpolymerisation in Gegenwart niedermolekularer Arzneistoffe. Bindungsartvon inkorporierten niedermolekularen
H Kopf (1977)
Extraction of pharmaceutically important chitin and carotenoids from shrimp biowaste by microbial fermentation method
K Prameela (2010)
Chitin and chitosan hydrogels
R.A.A. Muzzarelli (2009)
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.
Michael J. Heffernan (2011)
Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration.
S. Illum (1983)
N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Y. Kato (2004)
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
A. Fire (1998)
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
N. Desai (2006)
Quantum dots hold promise for early cancer imaging and detection
Pericles Pericleous (2012)
Appl Microbiol Biotechnol
Production, Properties, and Some New Applications of Chitin and Its Derivatives
J. Synowiecki (2003)
Antimetastatic and Growth‐inhibitory Effects of N‐Acetylchitohexaose in Mice Bearing Lewis Lung Carcinoma
K. Tsukada (1990)
Polymer conjugates for drug targeting. From inspired to inspiration!
R. Duncan (2006)
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
R. Yang (2009)
Pharmacokinetics of pegylated liposomal doxorubicin : review of animal and human stud
SL Gerson (2003)
Cancer statistics. CA Cancer J Clin
A Jemal (2010)
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
Depolymerization of N-succinyl-chitosan by hydrochloric acid.
Y. Kato (2002)
Targeted drug delivery
Jeffrey K. Mills (1999)
Chitosan chemistry and pharmaceutical perspective
Ravi KumarMNV (2004)
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
J. Kim (2008)
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
M. Aoshima (1977)
Cancer Statistics, 2010
A. Jemal (2010)
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.
D. Kwekkeboom (2008)
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
N-acylated chitosan: hydrophobic matrices for controlled drug release.
C. Le Tien (2003)
Targeting natural killer cells and natural killer T cells in cancer
E. Vivier (2012)
American Cancer Society Guidelines for the Early Detection of Cancer
R. Smith (2002)
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
A. Trouet (1982)
Drug release and antitumor characteristics of N-succinyl-chitosanmitomycin C as an implant
Y. Song (1996)
Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Y. Kato (2001)
Nanoparticles that communicate in vivo to amplify tumour targeting.
G. von Maltzahn (2011)
Cancer Statistics, 2006
A. Jemal (2006)
Antibacterial Characteristics and Activity of Water-Soluble Chitosan Derivatives Prepared by the Maillard Reaction
Y. Chung (2011)
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier systems for uptake in lymphocytes
S Balthasar (2005)
N. Dubrawsky (1989)
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
Advantages of liposomal delivery systems for anthracyclines.
T. Allen (2004)
Nanotechnology applications in cancer.
Shuming Nie (2007)
Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment
L. Serpe (2007)
Imatinib as a paradigm of targeted therapies
B. Druker (2003)
The blockade of immune checkpoints in cancer immunotherapy
D. Pardoll (2012)
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
Chitin and chitosan: Properties and applications
M. Rinaudo (2006)
12. Global Requirements for Medical Applications of Chitin and its Derivatives
M. H. Struszczyk (2006)
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
C. Coester (2000)
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
A. Gabizon (1997)
Human enzymatic activities related to the therapeutic administration of chitin derivatives
R. Muzzarelli (1997)
Colloidal systems for drug delivery: from design to therapy.
Mariana Beija (2012)
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
M. Yu (2012)
Preparation of chitosan gel beads by ionotropic molybdate gelation.
L. Dambies (2001)
Adjuvant synergy: the effects of nasal coadministration of adjuvants.
S. Moschos (2004)
Formation of branched-chain, soluble polysaccharides from chitosan
L. D. Hall (1980)
Recent advances of chitosan nanoparticles as drug carriers
J. Wang (2011)
How acute promyelocytic leukaemia revived arsenic
J. Zhu (2002)
Epoxy resin beads as a pharmaceutical dosage form. I. Method of preparation.
S. C. Khanna (1969)
Combining immunotherapy and targeted therapies in cancer treatment
M. Vanneman (2012)
Racial disparities in cancer therapy
C. Gross (2008)
Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery?
C. Kast (2002)
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
Intranasal delivery to brain Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration
L Henkin R480 Illum (1983)
6631 Gemcitabine and Oxaliplatine combination chemotherapy for metastatic well differentiated neuroendocrine carcinomas: a single-centre experience
Philippe A. Cassier (2009)
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
Nanomaterials for cancer therapy
C. Kumar (2006)
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection.
J. Haun (2010)
Chitin and chitosan hydrogels. In: Phillips GO, Williams PA (eds) Handbook of hydrocolloids
RAA Muzzarelli (2009)
Bio-Efficiency of Paediococcus acidilactici ATCC 8042 for Recovery of Chitin and Carotenoids in the Fermentation of Shrimp Biowaste
Kandra Prameela (2010)
Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment.
I. Park (2003)
Chitosan for mucosal vaccination.
I. M. van der Lubben (2001)
Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system
Y. Jeon (2002)
Nanogeometry: beyond drug delivery.
M. Ferrari (2008)
N4-Behenoyl-1-β-d-arabinofuranosylcytosine as a Potential New Antitumor Agent
Michiko Aoshima (1977)
In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
M. Sato (1996)
MicroRNA regulation by RNA-binding proteins and its implications for cancer
M. V. Kouwenhove (2011)
Octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles as potential carriers for targeted antitumor drug delivery.
Aifeng Zou (2012)
Characterization of polyacryl starch microparticles suitable as carrier for proteins and drugs
P Arthursson (1984)
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
Delivering nanomedicine to solid tumors
R. Jain (2010)
Chitin and chitosan polymers: Chemistry, solubility and fiber formation
C. K. S. Pillai (2009)
pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: in vitro characteristics and in vivo biocompatibility.
Ya-Ling Chiu (2009)
Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes.
H. Ueno (2001)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
M. Kulke (2006)
Multidrug resistance in cancer: role of ATP–dependent transporters
M. Gottesman (2002)
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶
W. Chen (2005)
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
S. Ekeblad (2007)
Bead polymerization technique for sustained-release dosage form.
S. C. Khanna (1970)
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well‐differentiated neuroendocrine carcinomas
P. Cassier (2009)
Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin
A. Gabizon (2012)
Nanocarriers as an emerging platform for cancer therapy
S. Wise (2007)
Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool
J. Murata (1997)
Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations.
S. Nsereko (2002)
Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose.
K. Suzuki (1986)
Efficient use of shrimp waste: present and future trends
Prameela Kandra (2011)
Cancer statistics. CA Cancer J Clin
A Jamal (2006)
Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.
A. Kono (1983)
Paul Ehrlich's magic bullet concept: 100 years of progress
K. Strebhardt (2008)
Electrochemically deposited metal nanoparticles for enhancing the performance of microfluidic MEMS in biochemical analysis
A. D. Bani-Yaseen (2009)
This paper is referenced by
The EZMTT cell proliferation assay provides precise measurement for drug combinations and better correlation between in vitro and in vivo efficacy.
Jingjing Rui (2020)
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
H. Zhang (2016)
Targeting Cancer Using Nanocarriers
Dalit Landesman-Milo (2016)
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
H. Han (2016)
Electrophoretic deposition of chitosan-based composite coatings for biomedical applications: A review
Egemen Avcu (2019)
A Regioselective Synthesis of Carbazole‐Appended Dispiropyrrolothiazoles/Pyrrolidines: Synthesis, Computational Studies and In Vitro Anticancer Activity
Kripalaya Ratheesh Arya (2019)
Overview on natural hydrophilic polysaccharide polymers in drug delivery
Fatemeh Abedini (2018)
Modified chitosan-based bioactive material for antimicrobial application: Synthesis and characterization.
Elton Marks de Araújo Braz (2018)
Recovery of Nutraceuticals from Agri-Food Industry Waste by Lactic Acid Fermentation
Lyned D. Lasrado (2018)
Eco-Friendly Extraction of Biopolymer Chitin and Carotenoids from Shrimp Waste
Kandra Prameela (2017)
Preparation of paclitaxel/chitosan co-assembled core-shell nanofibers for drug-eluting stent
Jing Tang (2017)
Biosynthesis of Silver Nanoparticles from Eucalyptus corymbia Leaf Extract at Optimized Conditions
Munyao Joshua Sila (2019)
Design, synthesis and anticancer activities of novel otobain derivatives.
Zhongzhou Li (2016)
Next generation nutraceutical from shrimp waste: The convergence of applications with extraction methods.
Kandra Prameela (2017)
Influence of chitosan nanoparticle-mediated C-erbB-2 gene silencing on invasion and apoptosis of Hep-2 cells.
W. Liu (2016)